Clinical relevance of brain volume changes in patients with cerebrotendinous xanthomatosis

S. Guerrera, M. L. Stromillo, A. Mignarri, M. Battaglini, S. Marino, C. Di Perri, A. Federico, M. T. Dotti, N. De Stefano

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Objective: To quantify total and regional brain damage in subjects with cerebrotendinous xanthomatosis (CTX) using MR based quantitative measures. Background: CTX is a rare inherited disorder characterised by progressive neurological impairment. Appropriate therapy can slow disease progression. Measures of brain volume changes have been used in several neurological disorders due to their value in assessing disease outcome and monitoring patients' evolution. Methods: 24 CTX patients underwent conventional MRI to measure total and regional brain volumes. In five CTX patients who started therapy at baseline, clinical and MRI examinations were repeated after 2 years. Clinical disability, overall cognitive performance and cerebellar function were evaluated using the modified Rankin Scale (RS), Mini Mental Status Examination (MMSE) and cerebellar functional system score (CB-FSS). Results: Measures of normalised brain, cortical and cerebellar volumes were lower in CTX patients than in healthy controls (p

Original languageEnglish
Pages (from-to)1189-1193
Number of pages5
JournalJournal of Neurology, Neurosurgery and Psychiatry
Volume81
Issue number11
DOIs
Publication statusPublished - Nov 2010

Fingerprint

Cerebrotendinous Xanthomatosis
Brain
Physiologic Monitoring
Nervous System Diseases
Disease Progression
Therapeutics

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Surgery

Cite this

Clinical relevance of brain volume changes in patients with cerebrotendinous xanthomatosis. / Guerrera, S.; Stromillo, M. L.; Mignarri, A.; Battaglini, M.; Marino, S.; Di Perri, C.; Federico, A.; Dotti, M. T.; De Stefano, N.

In: Journal of Neurology, Neurosurgery and Psychiatry, Vol. 81, No. 11, 11.2010, p. 1189-1193.

Research output: Contribution to journalArticle

Guerrera, S, Stromillo, ML, Mignarri, A, Battaglini, M, Marino, S, Di Perri, C, Federico, A, Dotti, MT & De Stefano, N 2010, 'Clinical relevance of brain volume changes in patients with cerebrotendinous xanthomatosis', Journal of Neurology, Neurosurgery and Psychiatry, vol. 81, no. 11, pp. 1189-1193. https://doi.org/10.1136/jnnp.2009.203364
Guerrera, S. ; Stromillo, M. L. ; Mignarri, A. ; Battaglini, M. ; Marino, S. ; Di Perri, C. ; Federico, A. ; Dotti, M. T. ; De Stefano, N. / Clinical relevance of brain volume changes in patients with cerebrotendinous xanthomatosis. In: Journal of Neurology, Neurosurgery and Psychiatry. 2010 ; Vol. 81, No. 11. pp. 1189-1193.
@article{065c7ccd30464e9cae4f84e09cb53f4c,
title = "Clinical relevance of brain volume changes in patients with cerebrotendinous xanthomatosis",
abstract = "Objective: To quantify total and regional brain damage in subjects with cerebrotendinous xanthomatosis (CTX) using MR based quantitative measures. Background: CTX is a rare inherited disorder characterised by progressive neurological impairment. Appropriate therapy can slow disease progression. Measures of brain volume changes have been used in several neurological disorders due to their value in assessing disease outcome and monitoring patients' evolution. Methods: 24 CTX patients underwent conventional MRI to measure total and regional brain volumes. In five CTX patients who started therapy at baseline, clinical and MRI examinations were repeated after 2 years. Clinical disability, overall cognitive performance and cerebellar function were evaluated using the modified Rankin Scale (RS), Mini Mental Status Examination (MMSE) and cerebellar functional system score (CB-FSS). Results: Measures of normalised brain, cortical and cerebellar volumes were lower in CTX patients than in healthy controls (p",
author = "S. Guerrera and Stromillo, {M. L.} and A. Mignarri and M. Battaglini and S. Marino and {Di Perri}, C. and A. Federico and Dotti, {M. T.} and {De Stefano}, N.",
year = "2010",
month = "11",
doi = "10.1136/jnnp.2009.203364",
language = "English",
volume = "81",
pages = "1189--1193",
journal = "Journal of Neurology, Neurosurgery and Psychiatry",
issn = "0022-3050",
publisher = "BMJ Publishing Group",
number = "11",

}

TY - JOUR

T1 - Clinical relevance of brain volume changes in patients with cerebrotendinous xanthomatosis

AU - Guerrera, S.

AU - Stromillo, M. L.

AU - Mignarri, A.

AU - Battaglini, M.

AU - Marino, S.

AU - Di Perri, C.

AU - Federico, A.

AU - Dotti, M. T.

AU - De Stefano, N.

PY - 2010/11

Y1 - 2010/11

N2 - Objective: To quantify total and regional brain damage in subjects with cerebrotendinous xanthomatosis (CTX) using MR based quantitative measures. Background: CTX is a rare inherited disorder characterised by progressive neurological impairment. Appropriate therapy can slow disease progression. Measures of brain volume changes have been used in several neurological disorders due to their value in assessing disease outcome and monitoring patients' evolution. Methods: 24 CTX patients underwent conventional MRI to measure total and regional brain volumes. In five CTX patients who started therapy at baseline, clinical and MRI examinations were repeated after 2 years. Clinical disability, overall cognitive performance and cerebellar function were evaluated using the modified Rankin Scale (RS), Mini Mental Status Examination (MMSE) and cerebellar functional system score (CB-FSS). Results: Measures of normalised brain, cortical and cerebellar volumes were lower in CTX patients than in healthy controls (p

AB - Objective: To quantify total and regional brain damage in subjects with cerebrotendinous xanthomatosis (CTX) using MR based quantitative measures. Background: CTX is a rare inherited disorder characterised by progressive neurological impairment. Appropriate therapy can slow disease progression. Measures of brain volume changes have been used in several neurological disorders due to their value in assessing disease outcome and monitoring patients' evolution. Methods: 24 CTX patients underwent conventional MRI to measure total and regional brain volumes. In five CTX patients who started therapy at baseline, clinical and MRI examinations were repeated after 2 years. Clinical disability, overall cognitive performance and cerebellar function were evaluated using the modified Rankin Scale (RS), Mini Mental Status Examination (MMSE) and cerebellar functional system score (CB-FSS). Results: Measures of normalised brain, cortical and cerebellar volumes were lower in CTX patients than in healthy controls (p

UR - http://www.scopus.com/inward/record.url?scp=78649587875&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649587875&partnerID=8YFLogxK

U2 - 10.1136/jnnp.2009.203364

DO - 10.1136/jnnp.2009.203364

M3 - Article

VL - 81

SP - 1189

EP - 1193

JO - Journal of Neurology, Neurosurgery and Psychiatry

JF - Journal of Neurology, Neurosurgery and Psychiatry

SN - 0022-3050

IS - 11

ER -